← Back to Search

Diagnostic Test

Bedside Ultrasound for Upper GI Bleeding

N/A
Recruiting
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after obtaining informed consent and prior to endoscopy being conducted.
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates the use of Point of Care Ultrasound (POCUS) as a diagnostic tool to check for food content in stomachs of people with upper GI bleeding before they go in for endoscopy.

Who is the study for?
This trial is for adults over 18 with upper GI bleeding who are scheduled for an endoscopy. It's not for those who've eaten solid food within the last 6 hours or clear liquids in the last 2, have had stomach surgery, gastric cancer, duodenal or bowel issues, or decline to consent.
What is being tested?
The study tests if bedside ultrasound (POCUS) can accurately identify retained gastric content before endoscopy in patients with upper GI bleeding. The goal is to improve safety by reducing aspiration risk during the procedure.
What are the potential side effects?
As this trial involves a non-invasive ultrasound assessment rather than medication, there are minimal expected side effects; however, discomfort from the positioning and pressure of the ultrasound probe may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after obtaining informed consent and prior to endoscopy being conducted.
This trial's timeline: 3 weeks for screening, Varies for treatment, and after obtaining informed consent and prior to endoscopy being conducted. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
measurement is gastric food content/blood.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Point of Care UltrasoundExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point of Care Ultrasound
2016
N/A
~30

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
316 Previous Clinical Trials
266,625 Total Patients Enrolled

Media Library

Point of Care Ultrasound (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT05763745 — N/A
Point of Care Ultrasound Research Study Groups: Point of Care Ultrasound
Point of Care Ultrasound Clinical Trial 2023: Point of Care Ultrasound Highlights & Side Effects. Trial Name: NCT05763745 — N/A
Point of Care Ultrasound (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05763745 — N/A
~18 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top